The FDA Fast-Tracks Its Review of Psilocybin and Methylone, 2 Promising Psychedelics
The agency issued "national priority vouchers" for the two drugs six days after President Donald Trump promised to facilitate approval of psychedelic therapies.
Original Source
Read the full article at Reason →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.